GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) » Definitions » Other Income (Expense)

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Other Income (Expense) : ¥-225 Mil (TTM As of Jun. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Tonghua Dongbao Pharmaceutical Co Other Income (Expense)?

Tonghua Dongbao Pharmaceutical Co's other income expense for the Tonghua Dongbao Pharmaceutical Co's pretax income for the three months ended in Jun. 2024 was ¥-277 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2024 was ¥-225 Mil.

Tonghua Dongbao Pharmaceutical Co Other Income (Expense) Historical Data

The historical data trend for Tonghua Dongbao Pharmaceutical Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Dongbao Pharmaceutical Co Other Income (Expense) Chart

Tonghua Dongbao Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.74 -26.18 255.05 925.51 58.21

Tonghua Dongbao Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.73 20.24 11.65 20.16 -277.30

Tonghua Dongbao Pharmaceutical Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-225 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tonghua Dongbao Pharmaceutical Co  (SHSE:600867) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Tonghua Dongbao Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) » Definitions » Other Income (Expense)
Comparable Companies
SZSE:300601 SZSE:000623 SHSE:600420 SHSE:688192 SZSE:300558 SHSE:603858 SHSE:600216 SZSE:300142 SHSE:600285 SHSE:600750 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XTAE:TEVA XSWX:SDZ NBIX NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
Dongbao Village, Jilin Province, Tonghua, CHN, 134123
Website
http://www.thdb.com
Tonghua Dongbao Pharmaceutical Co Ltd is a China-based firm. Its engaged in the production and distribution of pharmaceutical products. Its products include human insulin injection, Heart and brain capsule, Vitamin e soft capsule, and Oral detoxification products.
Executives
Cheng Jian Qiu Supervisors
Chang Xiao Hui Director
Li Cong Director
Li Feng Qin Director
Chen Hong senior management
Leng Chun Sheng Director
Li Yi Kui Director
Wang Dian Duo Supervisors
Wang Jun Ye Director
Han Jie Director

Tonghua Dongbao Pharmaceutical Co Headlines

No Headlines